Antibodies

View as table Download

Rabbit anti-CD22 Polyclonal Antibody

Applications ICC/IF, WB
Reactivities Mouse, Human, Rat
Conjugation Unconjugated
Immunogen Recombinant protein of human CD22

Rabbit polyclonal BL-CAM (Ab-807) antibody

Applications WB
Reactivities Human
Conjugation Unconjugated
Immunogen The antiserum was produced against synthesized non-phosphopeptide derived from human BL-CAM around the phosphorylation site of tyrosine 807 (G-D-YP-E-N).

Rabbit Polyclonal CD22 Antibody

Applications WB
Reactivities Human
Conjugation Unconjugated
Immunogen DNA immunization. This antibody was made against a protein fragment from the C Terminus Region

Anti-Human sCD22 Rabbit Polyclonal Antibody

Applications ELISA, WB
Reactivities Human
Conjugation Unconjugated
Immunogen CHO cells derived Recombinant Human sCD22

Anti-CD22 Rabbit Polyclonal Antibody

Applications WB
Reactivities Human
Conjugation Unconjugated
Immunogen Peptide sequence around aa.839~843 (N-V-D-Y-V) derived from Human CD22.

Biotinylated Anti-Human sCD22 Rabbit Polyclonal Antibody

Applications ELISA
Reactivities Human
Conjugation Unconjugated
Immunogen CHO cells derived Recombinant Human sCD22

Rabbit Polyclonal Anti-CD22 Antibody

Applications IHC
Reactivities Human
Conjugation Unconjugated
Immunogen Fusion protein of human CD22

CD22 rabbit monoclonal antibody, clone DM12

Applications ELISA, FC, IF, WB
Reactivities Human
Conjugation Unconjugated

CD22 rabbit monoclonal antibody, clone DM13

Applications ELISA, FC, IF, IP, WB
Reactivities Human
Conjugation Unconjugated

CD22 rabbit monoclonal antibody, clone DM14

Applications ELISA, FC, IF, IP
Reactivities Human
Conjugation Unconjugated

CD22 rabbit polyclonal antibody

Applications IHC
Reactivities Human
Conjugation Unconjugated
Immunogen Fusion protein of human CD22

Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))

Applications Bl, FC, IP
Reactivities Human, Monkey
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.